Drevet, Sabine
Tonetti, Jérôme
Bouzat, Pierre
Boudissa, Mehdi
Greze, Jules
Fajfrova, Olga
Allan-Pattoglia, Laure
Olive, Frederic
Bouisse, Magali
Boussat, Bastien
Bioteau, Catherine
Gavazzi, Gaetan
Article History
Received: 6 March 2025
Accepted: 12 June 2025
First Online: 11 July 2025
Declarations
:
: The study protocol adhered to the declaration of Helsinki. It was approved by the Personal Protection Committee (CPP). CPP is a French equivalent of Research Ethics Committees. All methods were performed in accordance with relevant guidelines and regulations. The study followed CNIL (National Commission on Informatics and Liberty) RGPD (General Data Protection Regulation) recommendations. Study registration within the internal register for processing activities of the DPO (Data Protection Officer) controller was performed prior to DRCI (Clinical Research and Innovation Delegation) approval. Informed consent was obtained from all patients and from legal guardians/families in case of participants with dementia. Patients and their families were informed about the study and could refuse to participate. Ethical approval of the study was provided on 10 November 2021 by the Institutional Review Board (IRB) from the Rhône-Alpes-Auvergne, Clermont-Ferrand (IRB #5891).
: Not applicable.
: The authors declare no competing interests.